Presentation - Session 4.3: Innovation in medicines

English (EN) (742.22 KB - PDF)

First published:
View

Presentation - Session 4.2: Programmes catered to academic developers PRIME, Orphan drugs, Paediatric drugs, Advanced Therapies, Repurposing

English (EN) (958.46 KB - PDF)

First published:
View

Presentation - Session 4.1: Engagement with Academia

English (EN) (2 MB - PDF)

First published:
View

Presentation - Session 3: Engagement with Stakeholders

English (EN) (391.08 KB - PDF)

First published:
View

Presentation - Session 2: Veterinary medicinal products specificities and challenges

English (EN) (1.65 MB - PDF)

First published:
View

Agenda - EMA Academia Info Day Agenda

English (EN) (529.25 KB - PDF)

First published: Last updated:
View
Research and development (veterinary medicines)

The European Medicines Agency (EMA) provides guidance and support to companies researching and developing veterinary medicines. This includes scientific and regulatory information on how to design and run clinical trials, compliance standards, how to establish maximum residue limits for medicines and biocides, support to innovation, and support the...

Last updated:
Research and development